Ozempic, Wegovy among drugs selected for Medicare's price negotiations
The Biden administration announced Friday that Ozempic, Wegovy and 13 additional drugs will now be covered under Medicare Part-D for price negotiations, the next round of negotiations under the Inflation Reduction Act passed by President Joe Biden in 2022.
With multiple stakeholders involved with different interests, the “specialty drug” definition can be a moving target.
The pharmaceutical landscape enters 2025 with a mix of challenges and opportunities, with the potential to shape the future ...
WWLP Springfield on MSN11d
Drug law will target costs, access, PBMsHealey plans to host a ceremony at 11 a.m. Wednesday with legislative leaders to sign both the prescription drug bill and a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback